ScholarIQanswers from OpenAlex

Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease

PaperCitations, authors & open-access status

Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease have?

ScholarIQcitation count

Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease has 2 citations in the OpenAlex counts ScholarIQ stores.

When was Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease published?

ScholarIQyear

Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease has 2025 year in the ScholarIQ index.

What is the open-access status of Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease?

ScholarIQoa status

Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease has closed oa status in the ScholarIQ index.

What is the DOI of Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease?

ScholarIQdoi

The DOI for Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease is on the source record.

What is the PMID of Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease?

ScholarIQpmid

The PMID for Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease is on the source record.

What is the OpenAlex record for Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease?

ScholarIQopenalex

The OpenAlex for Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial